Glucagon-like peptide-1 receptors agonists (GLP1 RA).
Copyright policy )Glucagon-like peptide-1 receptors agonists (GLP1 RA).
The glucagon-like peptide-1 receptors agonists (GLP1RA) are a relatively new class of drugs, used for management of type 2 diabetes. This review studies the characteristics of these drugs, focusing upon their mechanism of action, intra-class differences, and utility in clinical practice. It compares them with other incretin based therapies, the dipeptidyl peptidase-IV inhibitors, and predicts future developments in the use of these molecules, while highlighting the robust indications for the use of these drugs.
- Bharti Hospital India
Glucagon-Like Peptide 1, Diabetes Mellitus, Receptors, Glucagon, Humans, Hypoglycemic Agents, Insulin Resistance, Liraglutide, Glucagon-Like Peptide-1 Receptor
Glucagon-Like Peptide 1, Diabetes Mellitus, Receptors, Glucagon, Humans, Hypoglycemic Agents, Insulin Resistance, Liraglutide, Glucagon-Like Peptide-1 Receptor
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).9 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!